Skip to main content
. 2022 Feb 10;8(4):546–552. doi: 10.1001/jamaoncol.2021.7298

Figure 1. CONSORT Diagram.

Figure 1.

aA total of 136 patients did not start DCVAC/PCa (119 because of production failures and 19 for other reasons).

bBecause of a protocol violation, 4 patients in the placebo group received DCVAC/PCa; these 4 patients were included in the DCVAC/PCa group in the safety analysis set.

AE indicates adverse event; ICF, informed consent form.